0 results for 'Middletons'
4 Firms Advise on Billion-Dollar Australia-U.S. Stem Cell Deal
U.S. drugmaker Cephalon has announced that it will take a 20 percent stake in Australian biotechnology company Mesoblast as part of an alliance to develop and market stem cell treatments for degenerative conditions of the cardiovascular and central nervous systems.Seven Firms Advise on Mylan's $1.6 Billion Generic Drug Buy
Global generic drug and specialty pharmaceuticals maker Mylan has turned to Skadden, Arps, Slate, Meagher & Flom, Magic Circle shop Slaughter and May, and Indian firm Platinum Partners for counsel on its $1.6 billion acquisition of Indian generic injectable drug manufacturer Agila Specialties from parent Strides Arcolab. Haynes and Boone, Herbert Smith Freehills, and firms from Brazil and India are advising the seller.4 Firms Advise on Billion-Dollar Australia-U.S. Stem Cell Deal
U.S. drugmaker Cephalon will take a 20 percent stake in Australian biotech company Mesoblast in an alliance to develop and market stem cell treatments for cardiovascular and central nervous system conditions. Four firms are advising on the deal, which could be worth up to $1.7 billion.Marcellus Shale, Revenue Hunt Spur Pa. Firm Mergers
Pennsylvania firms have frequently been the subjects of law firm mergers in one of the most active quarters for merger activity the industry has seen since the beginning of 2009, according to a report by legal consultancy Altman Weil.Corporate Transparency Act Resource Kit
Brought to you by Wolters Kluwer
Download Now
Revenue, Profit, Cash: Managing Law Firms for Success
Brought to you by Juris Ledger
Download Now
Law Firm Operational Considerations for the Corporate Transparency Act
Brought to you by Wolters Kluwer
Download Now
The Ultimate Guide to Remote Legal Work
Brought to you by Filevine
Download Now